vialroom

#retatrutide 2024-10-11

Friday11 messages4 participantstimes are UTC
Highlights from this day
  • hr_log_hattie — research use only is on every vial and i treat it as exactly that, nobody here is prescribing 16:55
  • endotoxin_ed — there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists 17:12
  • hr_log_hattie — triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history 17:16
  • hr_log_hattie — appetite suppression at 1.7 was stronger than my tirzepatide experience at a comparable point 17:18
  • karl_fischer — stopped for 17 months and restarted at half my old dose, the ramp was easier second time 17:20
EE

triple agonist meaning GLP-1, GIP and glucagon, have i got that right

research use only is on every vial and i treat it as exactly that, nobody here is prescribing

EE

came off at 33 weeks because my resting rate stayed elevated and i didnt like it

there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists

KF

why does everyone insist on smaller steps here than on the other two

HL

triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history

appetite suppression at 1.7 was stronger than my tirzepatide experience at a comparable point

KF

stopped for 17 months and restarted at half my old dose, the ramp was easier second time

❤️4💀1